B

유한양행

000100KOSPI의약품 제조업

57.4 / 100

Reference Date: 2026-06-10

Financial Score21.5 / 40
News Sentiment18.9 / 25
Momentum5.0 / 20
Disclosure12.0 / 15
AI Analysis: ROE significantly exceeds the industry average but PER raises overvaluation concerns. Declined 12.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Yuhan is a company engaged in the manufacturing and sales of pharmaceuticals, chemicals, and daily necessities, with key products such as Lexapro, Antipurin, and DuoWell. In 2024, the company achieved a 5.7% revenue growth to 21.87 trillion won, despite challenges like geopolitical tensions and economic downturns. R&D efforts are highlighted by Lexapro's global commercialization and ongoing pipeline development, while operating profit and net income increased by 90.2% and 235.9% year-over-year, respectively.

Number of Employees

2,153people

Average Salary

100.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
32.96Industry Average 11.930.0Point

2.8x industry avg (risky)

PBR
2.59Industry Average 0.890.0Point

2.9x industry avg (risky)

ROE
8.21Industry Average 4.017.0Point

2.0x industry avg (excellent)

Debt Ratio
5.30Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲8.5% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲43.4% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 5.8% (improving, 3yr)

Detailed News Sentiment

50 totalPositive 37Neutral 10Negative 3Average Sentiment Score 75.7

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 76,700Won52-week high 135,80052-week low 76,700
1-month return1.0Point

1m -12.84% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

10 totalPositive 1Neutral 9Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-06-08
  • Neutral기업설명회(IR)개최(안내공시)2026-06-05
  • Neutral기업설명회(IR)개최(안내공시)2026-06-05
  • Neutral기업지배구조보고서공시2026-06-01
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-01